Abstract P4-14-15: Prospective study analyzing value of breast Density change predicting ENdocrine therapy response in postmenopausal women taking adjuvant ARomatase inhibitor [DEAR study] (interim analysis)

Mapping Intimacies ◽

10.1158/1538-7445.sabcs18-p4-14-15 ◽

2019 ◽

Author(s):

Y Kim ◽

E Lee ◽

H-B Lee ◽

KE Kim ◽

YW Ju ◽

...

Keyword(s):

Prospective Study ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Breast Density ◽

Interim Analysis ◽

Therapy Response ◽

Download Full-text

Abstract GS4-01: Ten-year results from NRG Oncology/NSABP B-42: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor+ breast cancer (BC) who have completed previous adjuvant therapy with an aromatase inhibitor (AI)

10.1158/1538-7445.sabcs19-gs4-01 ◽

2020 ◽

Author(s):

Eleftherios P Mamounas ◽

Hanna Bandos ◽

Barry C Lembersky ◽

Jeon Hyeon Jeong ◽

Charles E Geyer ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Adjuvant Therapy ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Adjuvant Endocrine Therapy ◽

Controlled Clinical Trial ◽

Download Full-text

Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement

Current Oncology ◽

10.3747/co.20.1316 ◽

2013 ◽

Vol 20 (1) ◽

Author(s):

K.I. Pritchard ◽

K.A. Gelmon ◽

D. Rayson ◽

L. Provencher ◽

Marc Webster ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Consensus Statement ◽

Inhibitor Therapy ◽

Aromatase Inhibitor Therapy ◽

Hormone Receptor Positive

Download Full-text

The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study

Breast Cancer Research and Treatment ◽

10.1007/s10549-013-2659-y ◽

2013 ◽

Vol 141 (1) ◽

pp. 111-117 ◽

Author(s):

Dominique Frechette ◽

Lise Paquet ◽

Shailendra Verma ◽

Mark Clemons ◽

Paul Wheatley-Price ◽

...

Keyword(s):

Breast Cancer ◽

Sexual Dysfunction ◽

Prospective Study ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Early Stage ◽

Early Stage Breast Cancer ◽

A Prospective Study ◽

Download Full-text

310 Breast Density Change as a Predictive Surrogate of Adjuvant Anti-estrogen Therapy Response in Estrogen Receptor Positive Breast Cancer

European Journal of Cancer ◽

10.1016/s0959-8049(12)70376-3 ◽

2012 ◽

Vol 48 ◽

pp. S133

Author(s):

J.S. Kim ◽

W. Han ◽

J.M. You ◽

H.C. Shin ◽

S.K. Ahn ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Breast Density ◽

Estrogen Therapy ◽

Therapy Response ◽

Density Change ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Abstract S1-05: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy (tx) with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer (BC) who have completed previous adjuvant tx with an aromatase inhibitor (AI): Results from NRG Oncology/NSABP B-42

10.1158/1538-7445.sabcs16-s1-05 ◽

2017 ◽

Author(s):

EP Mamounas ◽

H Bandos ◽

BC Lembersky ◽

CE Geyer ◽

L Fehrenbacher ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Adjuvant Endocrine Therapy ◽

Controlled Clinical Trial ◽

Download Full-text

Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First‐Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor‐Positive/HER2‐Negative Breast Cancer

The Oncologist ◽

10.1634/theoncologist.2014-0021 ◽

2014 ◽

Vol 19 (4) ◽

pp. 348-349 ◽

Author(s):

Beverly Moy ◽

Patrick Neven ◽

Fabienne Lebrun ◽

Meritxell Bellet ◽

Binghe Xu ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Trial ◽

Locally Advanced ◽

Hormone Receptor Positive

Download Full-text

Erratum to: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

Breast Cancer Research ◽

10.1186/bcr3353 ◽

2012 ◽

Vol 14 (6) ◽

Author(s):

Jisun Kim ◽

Wonshik Han ◽

Hyeong-Gon Moon ◽

Soo K Ahn ◽

Hee-Chul Shin ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Breast Density ◽

Hormone Receptor ◽

Adjuvant Endocrine Therapy ◽

Density Change ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

Breast Cancer Research ◽

10.1186/bcr3221 ◽

2012 ◽

Vol 14 (4) ◽

Author(s):

Jisun Kim ◽

Wonshik Han ◽

Hyeong-Gon Moon ◽

Soo Kyung Ahn ◽

Hee-Chul Shin ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Breast Density ◽

Hormone Receptor ◽

Adjuvant Endocrine Therapy ◽

Density Change ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India

Breast Cancer Targets and Therapy ◽

10.2147/bctt.s331831 ◽

2021 ◽

Vol Volume 13 ◽

pp. 625-640

Author(s):

Dimple Butani ◽

Nidhi Gupta ◽

Gaurav Jyani ◽

Pankaj Bahuguna ◽

Rakesh Kapoor ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Adjuvant Endocrine Therapy ◽

Switch Therapy ◽

Hormone Receptor Positive ◽

Download Full-text

Effect of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer after prior adjuvant therapy with an aromatase inhibitor (AI): NRG Oncology/NSABP B-42

10.1016/s0960-9776(17)30112-1 ◽

2017 ◽

Vol 32 ◽

pp. S25-S26 ◽

Author(s):

E. Mamounas ◽

H. Bandos ◽

B. Lembersky ◽

C. Geyer ◽

C. Geyer ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Adjuvant Endocrine Therapy

Download Full-text